Chengchao Chu Selected Research

Chengchao Chu Research Topics

Disease

29	Neoplasms (Cancer) 01/2024 - 11/2016
7	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 11/2018
3	Liver Neoplasms (Liver Cancer) 03/2023 - 01/2022
2	Corneal Neovascularization 12/2023 - 11/2023
2	Hyperthermia 12/2023 - 10/2020
2	Hypoxia (Hypoxemia) 11/2021 - 01/2020
1	Eye Diseases (Eye Disease) 03/2024
1	Choroidal Neovascularization 12/2023
1	Hemorrhage 12/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	Multiple Myeloma 01/2022
1	Bone Diseases (Bone Disease) 01/2022
1	Iron Overload 12/2021
1	Margins of Excision 10/2020
1	Brain Neoplasms (Brain Tumor) 06/2020
1	Glioblastoma (Glioblastoma Multiforme) 06/2020
1	Klatskin Tumor 03/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Infections 01/2020
1	Glioma (Gliomas) 01/2016

Drug/Important Bio-Agent (IBA)

6	Ethiodized Oil (Ethiodol)FDA Link 03/2023 - 10/2020
4	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2020
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2023 - 01/2017
3	Therapeutic UsesIBA 12/2023 - 11/2016
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2017
3	MetalsIBA 01/2022 - 11/2018
2	AntioxidantsIBA 03/2024 - 11/2023
2	Photosensitizing Agents (Photosensitizers)IBA 12/2023 - 06/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 02/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 03/2023 - 01/2020
2	CatalaseIBA 01/2023 - 10/2020
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2020
2	EnzymesIBA 11/2021 - 01/2020
2	Metal-Organic FrameworksIBA 01/2019 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 02/2018 - 01/2016
2	LigandsIBA 02/2018 - 01/2018
1	Free RadicalsIBA 03/2024
1	Phosphates (Orthophosphate)IBA 01/2024
1	BuffersIBA 01/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023
1	GoldIBA 10/2023
1	6-methyladenineIBA 01/2022
1	IonsIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	IronIBA 12/2021
1	MicellesIBA 01/2021
1	mahuang-tangIBA 10/2020
1	SolutionsIBA 06/2020
1	alpha-SynucleinIBA 01/2020
1	SynucleinsIBA 01/2020
1	Ferritins (Ferritin)IBA 07/2019
1	Peptides (Polypeptides)IBA 07/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Nanoparticle Drug Delivery SystemIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	zinc(II) dipicolylamineIBA 01/2019
1	eumelaninIBA 07/2018
1	ManganeseIBA 07/2018
1	Contrast MediaIBA 07/2018
1	liposomal doxorubicin (Doxil)FDA Link 02/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Death Domain ReceptorsIBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 06/2017
1	Coloring Agents (Dyes)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 11/2016
1	Factor VII (Proconvertin)IBA 01/2016
1	Thromboplastin (Tissue Factor)IBA 01/2016

Therapy/Procedure

21	Therapeutics 03/2024 - 11/2016
17	Precision Medicine 07/2023 - 01/2016
5	Drug Therapy (Chemotherapy) 10/2023 - 11/2016
4	Computer-Assisted Surgery (Image Guided Surgery) 03/2023 - 01/2022
3	Photothermal Therapy 10/2023 - 01/2018
2	Lasers (Laser) 12/2023 - 01/2018
2	Phototherapy (Light Therapy) 07/2019 - 06/2017
1	Hepatectomy 01/2022
1	Oncolytic Virotherapy 01/2019
1	Intravenous Injections 11/2018
1	Radiotherapy 11/2016